Skip to main content

Table 2 Median [Interquartile Range] of numbers of sputum specimens, total numbers of organisms and numbers of co-infecting organisms [per patient] in each group. Mean ± SD numbers of individual co-infecting organisms isolated per patient in each group.

From: Organisms isolated from adults with Cystic Fibrosis

Measurement

Patient Group

 

BCC

PA

NI

No. of Patients

23

30

26

Total No. of Specimens / patient

24 [9.0–59.0]

19.5 [5.5–34.5]

0 [0–9.8]

Total No. of Organisms / patient †

32 [16.0–79.0]

24 [7.8–46.3]

0 [0–11.3]

No. of Co-infecting Organisms / patient ‡

15 [8.0–20.0]

3.5 [0.8–11.3]

0 [0–4.3]

P. aeruginosa co-infection

14.4 ± 19.7

-

0.1 ± 0.3

S. aureus co-infection

3.6 ± 4.8

2.0 ± 4.1

3.7 ± 7.5

H. influenza co-infection

1.8 ± 2.9

0.7 ± 1.6

1.1 ± 3.1

S. pneumonia co-infection

0.6 ± 1.2

0.2 ± 0.5

0.4 ± 1.0

S. maltophilia co-infection

0.9 ± 1.5

2.6 ± 6.6

1.7 ± 6.3

Other organism co-infection

1.4 ± 1.9

3.1 ± 5.9

1.7 ± 3.2

  1. † Total number of different bacterial organisms isolated in that group of patients during the study period.
  2. ‡ Number different bacterial organisms isolated excluding those isolates for BCC or PA in those patients who are colonized with these bacteria.